No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
250 |
4. Check minimum number of eventsNone |
250 |
5. Include endpointsNone |
250 |
6. Filter based on genotype QC (FinnGen only) |
250 |
Control definitions (FinnGen only)
- Control exclude
- LUNG_TRANSPLANTATION
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Lung transplant status
based on the number of shared cases.
Similar with more cases:
- Transplanted organ and tissue status
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 624 | 258 | 366 |
| Only index persons | 563 | 236 | 327 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 54.70 | 58.10 |
| Only index persons | 56.77 | 54.70 | 58.26 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 250 | 102 | 148 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.07 |
| Median age at first event (years) | 57.14 | 54.70 | 58.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 222
- Matched controls
- 2220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z94.2
ICD-10 Finland
Lung transplant status
+∞
321.5
222
*
127
Kela drug reimbursment
Transplant complication
1132.0
242.1
199
17
L04AA06
ATC
mycophenolic acid; systemic
666.8
218.2
186
17
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
7168.3
214.6
171
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
199.2
160
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
135.7
161.5
166
47
UGC12
NOMESCO Finland
Flexible bronchoscopy
111.1
156.7
168
60
TGC00
NOMESCO Finland
Bronchial lavation
140.0
138.0
139
26
L04AD01
ATC
ciclosporin; systemic
144.2
133.6
134
23
GD1AD
NOMESCO Finland
Thorax CT examination
94.6
130.2
140
39
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
78.2
129.8
146
53
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
590.4
127.6
115
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
40.2
117.1
182
225
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
143.7
116.3
117
17
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
52.5
116.2
144
75
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
112.3
98
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
68.8
111.5
127
42
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
380.7
110.8
103
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
45.7
109.9
141
81
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
246.3
109.7
105
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
37.7
106.1
196
369
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
47.3
103.1
129
63
R4110
NOMESCO Finland
Physiotherapy
35.6
100.7
198
417
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
83.1
97.1
106
24
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
39.3
90.6
118
62
C08CA02
ATC
felodipine; oral
32.1
89.7
126
87
GD1AA
NOMESCO Finland
Thorax X-ray examination
50.8
88.4
212
653
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
44.4
83.5
104
43
XX4BW
NOMESCO Finland
NA
594.3
82.8
77
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
20.3
81.6
145
188
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
18.9
79.5
148
212
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
27.4
79.3
116
85
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
18.0
78.9
173
363
WX872
NOMESCO Finland
Intensive care
34.5
78.5
105
56
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
59.5
77.7
90
25
ZX108
NOMESCO Finland
Inhalation
269.8
75.3
73
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
27.8
68.3
97
60
WX404
NOMESCO Finland
Intravenous generell anesthesy
14.3
68.1
149
277
Z3226
NOMESCO Finland
Physiotherapist
14.6
68.1
143
244
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
78.5
67.1
74
14
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
99.2
64.7
69
10
Z2446
NOMESCO Finland
Social worker
19.8
62.8
102
91
H02AB06
ATC
prednisolone; systemic
16.5
61.8
197
717
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
19.2
61.5
101
92
J18.9
ICD-10 Finland
Pneumonia, unspecified
12.4
60.9
139
263
C10AA03
ATC
pravastatin; oral
25.3
60.5
88
56
C03CA01
ATC
furosemide; systemic
12.2
59.4
135
250
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
139.1
59.3
61
6
WX408
NOMESCO Finland
General anesthesy, balanced
11.1
57.9
159
412
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
11.7
57.4
133
251
Z2221
NOMESCO Finland
Medical doctor
10.6
55.9
152
378
ZXE40
NOMESCO Finland
More than seven and less than nine hours
43.9
55.3
68
22
A07AA02
ATC
nystatin; oral
26.7
55.1
78
44
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
17.8
53.4
89
80
5AB14
NOMESCO Finland
NA
219.3
51.3
51
*
ZX120
NOMESCO Finland
Intravenous
14.5
51.2
95
109
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
+∞
51.0
47
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
16.1
50.5
88
87
ZXA10
NOMESCO Finland
Bilateral
11.0
50.4
114
194
J96.1
ICD-10 Finland
Chronic respiratory failure
88.5
49.8
54
8
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
72.5
49.2
55
10
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
22.1
48.5
73
48
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
17.1
46.6
78
68
ZXE00
NOMESCO Finland
One hour or less
8.5
46.1
166
575
L04AX01
ATC
azathioprine; systemic
18.8
45.1
72
55
ZXE30
NOMESCO Finland
More than five and less than seven hours
17.6
45.1
74
61
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
187.0
44.6
45
*
ZXD10
NOMESCO Finland
Scheduled procedure
7.9
43.9
162
563
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
22.0
42.9
64
40
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
67.5
42.5
48
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.2
40.1
79
96
J01MA14
ATC
moxifloxacin; systemic
12.0
39.3
78
96
ZXE10
NOMESCO Finland
More than one and less than three hours
6.9
39.0
155
558
284
Kela drug reimbursment
Nintedanib and pirfenidone
436.6
38.2
37
*
RS123
NOMESCO Finland
NA
+∞
36.5
34
*
XG410
NOMESCO Finland
Flow-volume spirometry
19.8
36.4
56
37
JN4BD
NOMESCO Finland
Extensive body CT
9.9
36.3
81
122
C10AA01
ATC
simvastatin; oral
6.3
35.7
151
562
2AX04
NOMESCO Finland
NA
206.6
34.8
35
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
6.6
34.3
113
302
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
48.3
33.5
40
10
L04AX05
ATC
pirfenidone; oral
+∞
33.2
31
*
C07AB07
ATC
bisoprolol; oral
5.7
31.9
156
652
5BA08
NOMESCO Finland
NA
99.9
31.7
34
*
TK800
NOMESCO Finland
Hemodialysis
24.2
31.6
45
23
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
7.6
31.6
85
168
ZXD05
NOMESCO Finland
Urgent procedure
5.7
31.6
125
408
R03AC02
ATC
salbutamol; inhalant
6.0
31.5
171
799
C09AA05
ATC
ramipril; oral
6.1
31.4
109
303
TPH04
NOMESCO Finland
Cathetrisation of vein
6.3
31.2
102
262
XG466
NOMESCO Finland
Sleep oxymetry
18.2
31.1
49
34
3A006
NOMESCO Finland
NA
+∞
31.0
29
*
Z94.0
ICD-10 Finland
Kidney transplant status
36.0
30.7
39
13
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
10.5
29.9
62
79
356
Kela drug reimbursment
Nintedanib and pirfenidone
333.3
29.5
29
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
26.8
29.1
40
18
L04AA01
ATC
[U] ciclosporin; systemic
38.7
28.8
36
11
Z3231
NOMESCO Finland
Registered nurse
5.2
28.8
124
432
R4190
NOMESCO Finland
Nutritional therapy
13.0
28.5
52
51
R06.0
ICD-10 Finland
Dyspnoea
5.8
28.4
100
275
WX892
NOMESCO Finland
Monitored bed care
10.4
28.0
58
73
WX402
NOMESCO Finland
General anaesthesia
5.9
27.9
94
244
M05BA04
ATC
alendronic acid; oral
14.0
27.9
49
44
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
13.4
27.9
50
47
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
26.7
27.6
38
17
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
5.2
27.4
170
854
R03BB04
ATC
tiotropium bromide; inhalant
8.6
27.2
64
100
A02BA03
ATC
famotidine; systemic
15.0
27.1
46
38
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
22.2
26.8
39
21
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
9.4
26.5
58
80
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
292.9
26.3
26
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
25.0
25.8
36
17
TPH07
NOMESCO Finland
Cathetrisation of artery
7.4
25.7
67
122
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
44.7
25.6
31
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
9.9
25.5
54
70
WX740
NOMESCO Finland
Nitrogen oxide therapy
280.2
25.2
25
*
ZX197
NOMESCO Finland
NA
146.5
25.2
26
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.0
25.1
69
135
R50.9
ICD-10 Finland
Fever, unspecified
6.3
25.0
76
170
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
10.0
24.8
52
66
Z94.1
ICD-10 Finland
Heart transplant status
76.4
24.4
27
*
1CX01
NOMESCO Finland
NA
267.7
24.1
24
*
ZXA00
NOMESCO Finland
Right side
4.8
24.1
102
332
XJC10
NOMESCO Finland
Oesophageal pH monitoring
53.1
23.9
28
6
B01AB04
ATC
dalteparin; parenteral
16.1
23.9
39
29
A11CC03
ATC
alfacalcidol; systemic
25.6
23.8
33
15
AN1
HP
Coronary angiography
7.5
23.8
61
107
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.6
23.8
60
103
J01MA12
ATC
levofloxacin; systemic
5.5
23.7
82
213
XX4AW
NOMESCO Finland
NA
73.2
23.4
26
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
12.4
23.4
43
42
R03AK07
ATC
formoterol and budesonide; inhalant
5.1
23.0
87
249
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.2
22.6
145
685
ZX100
NOMESCO Finland
Oral
25.5
22.4
31
14
AK3
HP
BLTX (both lung transplants)
+∞
22.3
21
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
21.6
76
198
RS221
NOMESCO Finland
NA
24.5
21.5
30
14
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
8.0
21.3
51
80
137
Kela drug reimbursment
Uraemia requiring dialysis
33.9
21.1
27
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.8
21.0
57
107
J43.9
ICD-10 Finland
Emphysema, unspecified
63.7
20.3
23
*
N18.8
ICD-10 Finland
Other chronic renal failure
20.2
20.2
30
17
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
14.7
20.2
34
27
RD210
NOMESCO Finland
NA
16.8
20.1
32
22
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
218.7
19.9
20
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
16.1
19.8
32
23
XF400
NOMESCO Finland
ECG with 12 standard connections
4.8
19.7
76
216
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.6
19.5
79
236
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
19.2
71
192
Z49.2
ICD-10 Finland
Other dialysis
31.1
19.2
25
9
B05DA
ATC
Isotonic solutions
31.1
19.2
25
9
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.6
19.1
47
76
Z94.3
ICD-10 Finland
Heart and lungs transplant status
+∞
19.0
18
*
N02AX02
ATC
tramadol; systemic, rectal
3.7
19.0
134
650
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
206.7
18.8
19
*
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
206.7
18.8
19
*
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
33.4
18.8
24
8
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.4
18.4
61
146
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
16.5
18.2
29
20
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
18.2
53
108
TDM10
NOMESCO Finland
Puncture of maxillary antrum
11.6
18.2
34
34
J01GB01
ATC
tobramycin; inhalant, parenteral
194.9
17.8
18
*
GBB00
NOMESCO Finland
Tracheostomy
26.7
17.7
24
10
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
11.9
17.4
32
31
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.6
17.3
36
44
J01FA10
ATC
azithromycin; systemic
3.8
17.3
170
1033
Z3229
NOMESCO Finland
Other healthcare associate professional
5.9
17.3
52
110
RS230
NOMESCO Finland
NA
24.3
17.3
24
11
R52.0
ICD-10 Finland
Acute pain
15.1
17.0
28
21
B01AA03
ATC
warfarin; systemic
4.7
16.9
65
181
N02AA05
ATC
oxycodone; systemic
5.7
16.9
52
113
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
97.5
16.8
18
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
97.5
16.8
18
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
183.2
16.7
17
*
JN4AD
NOMESCO Finland
Body CT examination
7.2
16.7
42
70
A02BC05
ATC
esomeprazole; systemic
3.4
16.6
122
585
R03AC13
ATC
formoterol; inhalant
11.4
16.6
31
31
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
12.7
16.3
29
26
C10AX09
ATC
ezetimibe; oral
5.5
16.0
51
115
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.3
15.9
67
203
Z94.4
ICD-10 Finland
Liver transplant status
91.7
15.8
17
*
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
171.6
15.7
16
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
171.6
15.7
16
*
I27.0
ICD-10 Finland
Primary pulmonary hypertension
171.6
15.7
16
*
RK320
NOMESCO Finland
NA
41.3
15.7
19
5
B03XA01
ATC
erythropoietin; parenteral
41.3
15.7
19
5
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
41.3
15.7
19
5
H02AB04
ATC
methylprednisolone; systemic
4.5
15.5
61
172
WW200
NOMESCO Finland
Immunization
11.3
15.5
29
29
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
15.5
29
29
B05DB
ATC
Hypertonic solutions
34.4
15.1
19
6
B03XA02
ATC
darbepoetin alfa; parenteral
20.2
15.0
22
12
J01CA04
ATC
amoxicillin; systemic
5.1
15.0
203
1506
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
27.3
15.0
20
8
SAA03
NOMESCO Finland
Extended examination of mouth
3.1
14.8
122
621
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
+∞
14.7
14
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
20.9
14.5
21
11
Z49.1
ICD-10 Finland
Extracorporeal dialysis
20.9
14.5
21
11
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.5
14.5
45
98
Z01.8
ICD-10 Finland
Other specified special examinations
3.6
14.3
78
291
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
10.2
14.2
28
31
ZX121
NOMESCO Finland
Central venous catheter
32.4
14.1
18
6
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
5.7
14.1
42
87
B07.9
ICD-10 Finland
Verruca simplex
8.7
13.9
30
39
H26.3
ICD-10 Finland
Drug-induced cataract
36.6
13.7
17
5
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
+∞
13.7
13
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
12.7
13.7
24
21
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
148.7
13.6
14
*
AP2
HP
Catheterization of the right side of the heart
148.7
13.6
14
*
304
Kela drug reimbursment
Dornase alfa
148.7
13.6
14
*
WX002
NOMESCO Finland
Sedation and analgesia
3.7
13.5
68
237
Z49.0
ICD-10 Finland
Preparatory care for dialysis
42.9
13.3
16
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
18.2
13.3
20
12
SPAT1325
SPAT
Vaccination
3.1
13.0
96
441
R03DA04
ATC
theophylline; systemic, rectal
9.7
12.9
26
30
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.8
12.9
60
195
A02BC02
ATC
pantoprazole; systemic
3.0
12.8
163
1060
M81.9
ICD-10 Finland
Osteoporosis, unspecified
14.4
12.7
21
16
A02BC01
ATC
omeprazole; systemic
3.2
12.7
83
348
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
26.1
12.7
17
7
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
26.1
12.7
17
7
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
+∞
12.6
12
*
FXE00
NOMESCO Finland
Use of ECLA
+∞
12.6
12
*
C02KX01
ATC
bosentan; oral
+∞
12.6
12
*
3A064
NOMESCO Finland
NA
+∞
12.6
12
*
J01XB01
ATC
colistin; inhalant, parenteral
137.4
12.6
13
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
137.4
12.6
13
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.1
12.3
34
64
RK110
NOMESCO Finland
NA
22.9
12.2
17
8
R03BB01
ATC
ipratropium bromide; inhalant
12.8
12.1
21
18
JN4CD
NOMESCO Finland
Very extensive body CT
8.5
12.0
26
34
A12AA04
ATC
calcium carbonate; oral
15.8
12.0
19
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.9
12.0
27
38
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.9
11.9
25
31
6BA02
NOMESCO Finland
NA
68.7
11.7
13
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
5.7
11.7
34
68
R03AC03
ATC
terbutaline; inhalant
4.1
11.6
48
140
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
11.6
11
*
V03AE02
ATC
sevelamer; oral
126.3
11.5
12
*
J02AC03
ATC
voriconazole; systemic
126.3
11.5
12
*
L01XE31
ATC
[U] nintedanib; oral
126.3
11.5
12
*
B02.9
ICD-10 Finland
Zoster without complication
6.5
11.5
30
52
N18.0
ICD-10 Finland
End-stage renal disease
37.2
11.4
14
*
I50.9
ICD-10 Finland
Heart failure, unspecified
5.3
11.4
35
75
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
12.1
11.3
20
18
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
26.6
11.3
15
6
J45.9
ICD-10 Finland
Asthma, unspecified
3.5
11.3
60
215
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.7
11.2
39
96
WX720
NOMESCO Finland
Own respiration
7.9
11.1
25
35
M01AH05
ATC
etoricoxib; oral
0.3
11.1
51
1027
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.0
11.0
36
83
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.1
10.9
45
130
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
7.2
10.9
26
40
TK820
NOMESCO Finland
Peritoneal dialysis
29.7
10.9
14
5
3AC01
NOMESCO Finland
NA
22.8
10.8
15
7
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
22.8
10.8
15
7
N03AX16
ATC
pregabalin; oral
3.0
10.8
75
324
RS220
NOMESCO Finland
NA
12.1
10.8
19
17
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.1
10.7
29
53
R03BA02
ATC
budesonide; inhalant
3.4
10.7
58
210
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
15.2
10.7
17
12
J05AB11
ATC
valaciclovir; oral
3.8
10.6
48
151
R28
ICPC
Limited function/disability (R)
17.1
10.5
16
10
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
115.2
10.5
11
*
348
Kela drug reimbursment
Roflumilast
115.2
10.5
11
*
J43.1
ICD-10 Finland
Panlobular emphysema
+∞
10.5
10
*
R05CB01
ATC
acetylcysteine; inhalant, oral
34.3
10.4
13
*
EBA10
NOMESCO Finland
Surgical removal of tooth
3.7
10.4
49
159
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
20.0
10.4
15
8
N17.8
ICD-10 Finland
Other acute renal failure
24.8
10.4
14
6
G04BE03
ATC
sildenafil; oral
14.0
10.3
17
13
N17.9
ICD-10 Finland
Acute renal failure, unspecified
8.3
10.2
22
29
A09AA02
ATC
multienzymes (lipase, protease etc.)
15.6
10.2
16
11
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
6.7
10.0
25
41
602
Kela drug reimbursment
Children's severe malnutrition
21.2
9.9
14
7
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.5
9.9
49
166
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.7
9.8
28
55
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
57.6
9.7
11
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
57.6
9.7
11
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.9
9.7
32
74
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
16.0
9.7
15
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
9.6
41
122
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.7
9.6
33
80
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
13.2
9.5
16
13
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
31.5
9.5
12
*
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
104.3
9.5
10
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
104.3
9.5
10
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
104.3
9.5
10
*
B01AC11
ATC
iloprost; inhalant, parenteral
+∞
9.4
9
*
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
9.4
9
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
14.5
9.3
15
11
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
19.6
9.0
13
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
9.0
98
536
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
25.2
9.0
12
5
SPAT1262
SPAT
Handing over of treatment supplies
3.0
8.9
59
242
J01DB01
ATC
cefalexin; oral
3.1
8.9
193
1518
K05.30
ICD-10 Finland
Periodontitis complex
3.4
8.9
46
160
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.2
8.8
27
58
XJC00
NOMESCO Finland
Oesophageal manometry
52.1
8.7
10
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
52.1
8.7
10
*
GD1LA
NOMESCO Finland
GD
12.3
8.7
15
13
TK810
NOMESCO Finland
Hemofiltration
17.1
8.7
13
8
J47
ICD-10 Finland
Bronchiectasis
17.1
8.7
13
8
V03AE01
ATC
polystyrene sulfonate; oral
17.1
8.7
13
8
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
17.1
8.7
13
8
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.3
8.6
32
84
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
28.8
8.6
11
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
13.5
8.5
14
11
L57.0
ICD-10 Finland
Actinic keratosis
4.6
8.5
29
70
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
93.5
8.5
9
*
V03AG01
ATC
sodium cellulose phosphate; systemic
93.5
8.5
9
*
GX1K5
NOMESCO Finland
Diffusion capacity
93.5
8.5
9
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.0
8.4
20
31
XW000
NOMESCO Finland
Bone marrow biopsy
6.5
8.4
21
35
L04AA05
ATC
[U] tacrolimus; systemic
+∞
8.4
8
*
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
+∞
8.4
8
*
JD1FN
NOMESCO Finland
Scintigraphy of gastric function
+∞
8.4
8
*
WX721
NOMESCO Finland
Oxygen concentrator therapy
+∞
8.4
8
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.5
8.4
81
415
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.4
8.2
14
12
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
9.5
8.2
16
18
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.3
8.2
115
707
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
18.0
8.2
12
7
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
8.1
58
249
HA1AA
NOMESCO Finland
X-ray mammography
5.1
8.1
25
54
K06.18
ICD-10 Finland
Another gingival hyperplasia
23.0
8.1
11
5
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.2
8.1
45
165
ZXA05
NOMESCO Finland
Left side
2.6
8.0
65
302
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
13.7
8.0
13
10
J45.1
ICD-10 Finland
Nonallergic asthma
4.2
8.0
30
80
J01AA02
ATC
doxycycline; systemic
2.6
8.0
180
1386
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
5.7
7.9
22
42
K65.0
ICD-10 Finland
Acute peritonitis
15.8
7.8
12
8
RS310
NOMESCO Finland
NA
46.6
7.8
9
*
B01AB10
ATC
tinzaparin; parenteral
4.8
7.7
25
57
H02AB09
ATC
hydrocortisone; systemic
8.5
7.7
16
20
I20.99
ICD-10 Finland
Angina pectoris, unspecified
5.2
7.7
23
48
N02BE01
ATC
paracetamol; systemic, rectal
2.8
7.7
191
1531
R99
ICPC
Respiratory disease other
12.5
7.7
13
11
B34.9
ICD-10 Finland
Viral infection, unspecified
7.6
7.6
17
24
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
26.0
7.6
10
*
UJC12
NOMESCO Finland
Flexible oesophagoscopy
26.0
7.6
10
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.6
7.5
25
59
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.8
7.5
31
90
TQW99
NOMESCO Finland
Other minor procedure on skin
5.5
7.5
21
41
GX1D5
NOMESCO Finland
Flow volume spirometry
82.7
7.5
8
*
R03DX07
ATC
roflumilast; oral
82.7
7.5
8
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
9.9
7.4
14
15
TFP20
NOMESCO Finland
Cardiodefibrillation
4.2
7.4
27
70
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.2
7.4
27
70
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
7.4
37
126
AA1AD
NOMESCO Finland
CT of head and brain
2.6
7.4
57
257
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
7.7
7.3
16
22
115
NOMESCO Finland
NA
+∞
7.3
7
*
ZX196
NOMESCO Finland
NA
+∞
7.3
7
*
GDA10
NOMESCO Finland
Biopsy of lung
+∞
7.3
7
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
16.4
7.3
11
7
R05CB02
ATC
bromhexine; systemic
16.4
7.3
11
7
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
16.4
7.3
11
7
WX722
NOMESCO Finland
PEEP
5.1
7.3
22
47
K03.66
ICD-10 Finland
Tooth plaque
4.0
7.2
28
77
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
7.2
28
77
J01MA02
ATC
ciprofloxacin; systemic
2.2
7.2
98
583
J96.0
ICD-10 Finland
Acute respiratory failure
12.6
7.2
12
10
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.5
7.2
33
105
L03AA02
ATC
filgrastim; parenteral
7.4
7.1
16
23
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.8
7.1
19
35
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.2
7.1
21
44
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.4
7.0
20
40
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
14.4
7.0
11
8
R04.2
ICD-10 Finland
Haemoptysis
7.1
7.0
16
24
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
6.9
18
32
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.8
6.9
13
14
WX199
NOMESCO Finland
Other local analgesia
9.8
6.9
13
14
UJF32
NOMESCO Finland
Coloscopy
2.4
6.9
67
340
ZXC50
NOMESCO Finland
Cryotherapy
7.6
6.8
15
21
R4130
NOMESCO Finland
Speech therapy
7.6
6.8
15
21
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.5
6.8
19
37
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
17.4
6.8
10
6
EB1WA
NOMESCO Finland
NA
17.4
6.8
10
6
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
41.4
6.8
8
*
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
41.4
6.8
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
41.4
6.8
8
*
A01AB09
ATC
miconazole; local oral
3.9
6.8
27
76
K29.7
ICD-10 Finland
Gastritis, unspecified
6.8
6.8
16
25
J01FF01
ATC
clindamycin; systemic
2.3
6.7
72
382
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.2
6.7
14
18
H25.1
ICD-10 Finland
Senile nuclear cataract
2.9
6.7
41
159
A07AA09
ATC
vancomycin; oral
12.8
6.7
11
9
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.1
6.6
13
15
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.1
6.6
25
67
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
7.2
6.6
15
22
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
6.6
31
100
J05AB01
ATC
aciclovir; systemic
2.5
6.6
57
270
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
6.6
37
136
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.8
6.5
14
19
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.5
6.5
30
96
WZC30
NOMESCO Finland
Teaching
2.7
6.5
47
203
Z31.5
ICD-10 Finland
Genetic counselling
5.5
6.5
18
35
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
71.8
6.5
7
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
14.9
6.5
10
7
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.8
6.4
17
31
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
8.6
6.4
13
16
XG460
NOMESCO Finland
Short time oxymetry
8.6
6.4
13
16
C03DA01
ATC
spironolactone; oral
3.4
6.4
30
97
C01AA05
ATC
digoxin; systemic
5.1
6.4
19
40
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.8
6.4
26
75
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
9.7
6.4
12
13
ZY000
NOMESCO Finland
Hospital inpatient
9.7
6.4
12
13
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
11.5
6.4
11
10
Z50.1
ICD-10 Finland
Other physical therapy
4.5
6.3
21
50
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
18.7
6.3
9
5
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
18.7
6.3
9
5
RS224
NOMESCO Finland
NA
18.7
6.3
9
5
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
+∞
6.3
6
*
B01AC21
ATC
treprostinil; parenteral
+∞
6.3
6
*
334
Kela drug reimbursment
Treprostinil
+∞
6.3
6
*
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
+∞
6.3
6
*
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
+∞
6.3
6
*
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
C02KX04
ATC
macitentan; oral
+∞
6.3
6
*
N02AA01
ATC
morphine; systemic, rectal
+∞
6.3
6
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
+∞
6.3
6
*
JC2FN
NOMESCO Finland
Scintigraphy of oesophageal function
+∞
6.3
6
*
R03AC12
ATC
salmeterol; inhalant
6.1
6.3
16
28
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.1
6.3
16
28
XX7LW
NOMESCO Finland
NA
27.5
6.3
8
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
27.5
6.3
8
*
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
27.5
6.3
8
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.6
6.2
27
82
J01FA06
ATC
roxithromycin; oral
2.1
6.2
95
586
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.0
6.2
13
17
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.1
6.2
23
61
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.1
6.2
34
122
R01AD09
ATC
mometasone; nasal
2.0
6.2
104
668
C02CA01
ATC
prazosin; oral
13.0
6.1
10
8
XF602
NOMESCO Finland
Bloodpressure monitoring
13.0
6.1
10
8
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
9.0
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
195
78
110.09
309.32
6.3
3.2
—
—
—
0
0
(44790047)
189
34
224.72
307.65
5.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
196
59
150.17
307.65
5.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
195
60
144.18
307.65
5.8
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
185
43
162.63
307.65
5.1
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
192
48
169.10
307.65
5.5
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
180
35
181.10
307.65
4.5
1.6
—
—
—
0
0
(44790049)
189
34
224.72
307.65
5.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
184
35
196.35
307.65
4.4
1.5
—
—
—
0
0
(44806118)
189
34
224.72
307.65
5.6
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
187
46
158.35
307.65
4.9
1.6
—
—
—
0
0
(44790048)
189
34
224.72
307.65
5.6
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
212
50
273.37
307.65
12.7
4.6
u/ml
960.1
4920.0
—
16
5
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
191
24
333.98
307.65
5.3
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
214
64
226.26
307.65
40.8
8.2
iu/ml
190.8
474.5
0.54
103
13
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
193
26
322.19
307.65
5.1
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
233
187
169.53
280.45
38.1
10.9
mmol/l
10.2
8.7
1.89
233
180
(3003458) Phosphate [Moles/volume] in Serum or Plasma
231
272
99.59
219.86
20.2
8.7
mmol/l
1.1
1.1
0.76
231
256
(3023419) Bacteria identified in Sputum by Culture
121
32
72.34
208.20
4.5
2.7
—
—
—
0
0
(4010399)
177
146
39.09
201.12
4.5
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
209
242
47.56
197.09
7.1
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
209
248
46.29
193.77
34.7
8.5
mmol/l
105.2
103.7
3.77
209
241
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
208
245
45.58
193.66
7.2
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
164
8
591.89
186.68
4.3
1.4
ug/l
35.1
71.1
—
164
8
(3024932) HLA-DR beta [Type]
93
10
147.50
184.74
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
93
10
147.50
184.74
1.0
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
229
355
65.89
177.31
38.6
4.3
mmol/l
0.8
0.8
5.22
229
335
(3000494) Fungus identified in Specimen by Culture
205
269
37.78
176.04
8.9
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
123
63
37.46
170.47
1.6
1.5
—
—
—
0
0
(3000492) Spirometry study
187
222
30.46
169.80
6.7
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
97
25
62.76
165.94
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
217
336
42.35
165.87
7.4
2.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
128
78
32.58
164.66
7.4
2.3
ug/l
396.9
291.9
0.53
128
72
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
98
28
56.92
163.34
3.7
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
98
28
56.92
163.34
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
148
9
398.24
162.80
4.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
100
32
51.42
161.62
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
100
32
51.42
161.62
2.3
2.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
117
60
35.77
161.49
1.5
1.5
u/ml
103.4
84.9
—
13
10
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
118
66
32.97
156.94
6.6
2.9
u/ml
0.3
0.4
1.29
65
40
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
98
34
46.76
154.37
3.7
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
90
23
60.58
153.73
5.5
3.2
—
—
—
0
0
(4306422)
98
35
45.41
152.96
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
205
323
30.70
152.36
7.5
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
115
65
31.91
151.95
1.2
1.5
u/ml
412.9
214.7
4.14
88
35
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
207
333
31.33
151.54
9.5
2.8
e6/l
0.8
2.0
1.76
179
186
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
114
68
29.98
146.84
1.2
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
96
42
36.48
139.44
3.2
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
91
38
37.08
134.10
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
91
39
36.12
132.82
1.3
1.3
u/ml
4.0
5.6
0.31
43
18
(3048929) Epstein Barr virus Ab [Presence] in Serum
117
93
22.77
130.02
1.3
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
190
325
21.19
129.28
7.7
2.6
s
29.7
29.5
0.14
190
317
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
89
39
34.88
128.68
1.2
1.3
u/ml
2.9
7.3
0.33
27
12
(3042733) HLA Ab [Presence] in Serum
117
9
241.91
121.96
4.3
4.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
136
160
17.45
118.76
2.8
2.5
ug/l
35.9
9.2
12.74
136
140
(3018418) pH of Serum or Plasma
232
570
43.64
117.79
19.5
4.6
ph
7.4
7.4
1.72
46
112
(3033658) Prothrombin time (PT) actual/Normal
221
526
28.60
113.90
19.4
4.4
%
100.4
91.4
5.39
221
520
(3026782) Osmolality of Urine
196
400
19.06
113.86
10.6
2.7
mosm/kgh2o
548.6
584.9
1.41
190
343
(36304419) Bacteria [Presence] in Urine
226
568
32.03
110.81
15.8
2.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
203
455
19.41
108.31
4.1
1.5
g/l
2.1
2.5
2.23
194
282
(3030467) Casts [#/volume] in Urine by Automated count
226
588
30.62
106.68
16.1
3.0
e6/l
0.1
0.4
2.09
214
445
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
160
277
14.27
103.99
5.3
2.7
%
18.9
23.4
3.14
148
241
(40758558) Short blood count panel - Blood
215
539
22.35
103.71
30.3
7.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
180
365
15.04
102.98
9.4
2.7
e6/l
0.2
1.0
5.06
160
217
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
65
21
41.48
102.76
2.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
227
643
28.50
97.42
18.0
3.1
e6/l
7.7
145.2
0.79
218
504
(3006184) Hemoglobin [Mass/volume] in Capillary blood
73
44
23.02
91.17
2.6
2.5
g/l
120.9
136.2
2.04
17
35
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
107
128
13.87
90.02
7.8
3.5
ng/l
142.8
180.3
0.47
102
110
(3011397) Hemoglobin [Presence] in Urine by Test strip
191
473
13.87
89.75
6.7
3.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
215
616
18.79
88.89
16.5
2.2
u/l
88.2
215.1
4.57
215
583
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
67
37
24.37
86.84
2.3
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
233
761
31.32
85.02
19.5
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
231
750
28.37
84.54
44.9
6.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
228
735
24.89
83.63
22.4
3.5
e6/l
25.1
109.1
0.83
219
535
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
109
149
12.20
82.67
2.7
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
112
160
11.87
82.10
1.6
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
197
559
12.91
79.63
10.4
4.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
241
965
42.55
78.69
49.5
8.5
mmol/l
1.2
1.2
2.57
234
822
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
218
728
16.58
74.58
17.9
3.8
u/l
25.5
33.9
6.62
218
693
(3000991) Gas panel - Venous blood
113
184
10.38
73.86
42.7
10.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
122
229
9.45
70.23
38.1
8.7
mmol/l
1.5
1.2
0.32
111
188
(3012516) Albumin [Mass/volume] in Urine
193
594
10.86
69.77
5.0
3.5
mg/l
73.7
170.6
0.41
159
389
(3019060) Gas panel - Arterial blood
95
136
10.65
68.43
6.3
5.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
111
192
9.60
68.41
12.6
5.3
%
0.6
0.8
0.37
63
65
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
170
466
9.28
68.38
5.9
2.0
mg/l
1.5
1.2
0.49
149
362
(3034426) Prothrombin time (PT)
41
12
40.67
65.69
1.0
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
194
628
10.33
65.65
5.3
4.2
mg/mmol
12.3
10.1
0.22
159
402
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
42
14
35.86
64.82
1.2
1.1
—
—
—
0
0
(4268621)
52
32
20.26
63.41
2.2
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
364
7.97
61.40
5.8
3.9
ng/l
3545.7
436.0
4.51
137
276
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
81
109
10.51
60.70
8.8
7.8
mmol/l
24.1
24.1
0.02
70
101
(3017143) Hepatitis C virus Ab [Presence] in Serum
123
268
8.07
60.55
2.0
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
104
192
8.56
59.67
10.1
6.6
mmol/l
1.5
1.8
0.26
87
161
(3007853) Bacteria identified in Skin by Aerobe culture
120
265
7.79
57.97
2.7
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
42
15.74
56.42
3.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
51
38
16.60
56.17
3.2
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
307
7.38
55.77
2.0
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
154
453
7.25
54.99
3.7
2.1
mg/l
3.3
3.2
0.25
148
393
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
162
500
7.36
54.96
5.2
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
230
1000
17.25
54.82
48.3
9.9
e9/l
0.0
0.0
0.83
210
823
(3015736) pH of Urine
200
786
8.72
51.42
8.0
3.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
93
176
7.82
51.41
11.9
5.2
%
0.6
0.3
1.88
42
48
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
74
116
8.64
48.23
54.3
9.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
200
819
8.21
48.05
18.6
8.1
inr
1.2
1.1
0.77
56
256
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
36
15.02
47.36
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
36
15.02
47.36
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
32
12
30.43
47.16
1.6
1.4
e6/l
2310.4
1300.6
—
23
7
(3025159) Blasts/100 leukocytes in Blood
87
170
7.32
46.21
12.9
5.6
%
0.0
0.0
0.80
48
51
(3044640) Blood type and Crossmatch panel - Blood
177
668
6.65
45.86
5.6
2.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
30
10
33.95
45.84
1.5
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
10
33.95
45.84
1.6
1.5
e6/l
145048.1
33838.0
—
21
5
(40768804) Tissue Pathology biopsy report
197
820
7.62
45.64
5.0
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
377
6.10
45.46
2.0
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
50
9
68.95
44.36
1.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
86
174
7.01
43.96
13.7
5.6
%
0.2
0.2
0.00
57
57
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
119
7.94
43.33
2.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
30
12
28.27
43.14
1.5
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
78
146
7.31
42.93
8.0
5.2
ng/l
115.4
86.0
1.69
69
133
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
306
5.91
42.20
1.4
1.9
%
1.6
1.5
0.19
102
274
(3027945) Reticulocytes/100 erythrocytes in Blood
98
234
6.24
42.03
7.1
3.3
%
1.8
1.8
0.05
98
216
(3052851) Hemolysis interference index of Serum or Plasma
52
62
10.33
41.93
5.5
3.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
32
18
20.24
40.11
2.7
3.6
%
119.5
97.3
1.27
32
18
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
60
10.17
40.05
1.6
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
112
315
5.63
39.71
1.9
1.4
titre
398.8
409.7
0.03
34
66
(3035350) Ketones [Presence] in Urine by Test strip
212
1017
8.14
39.70
11.0
3.4
estimate
0.0
0.0
0.00
51
205
(3021601) Nitrite [Presence] in Urine by Test strip
212
1020
8.09
39.47
15.9
4.6
estimate
0.0
0.0
0.00
54
212
(3009261) Glucose [Presence] in Urine by Test strip
213
1034
8.16
39.11
10.9
3.4
estimate
0.0
0.0
0.00
54
204
(3051651) Icteric interference index of Serum or Plasma
32
19
19.17
39.10
6.5
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
51
10.83
39.00
1.6
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
261
5.72
38.47
4.6
3.8
umol/l
5.9
10.0
1.51
90
234
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
30
14.30
38.39
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
36
12.65
37.36
1.3
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
142
508
5.16
37.16
5.3
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
237
1308
16.61
37.01
23.3
3.8
e6/l
1.9
175.2
0.56
11
21
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
84
194
6.01
36.86
2.7
2.7
u/l
39.7
32.2
0.91
78
162
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
26
11
26.26
36.48
1.5
1.2
u/l
316.4
323.5
0.01
26
11
(3051611) Lipemic interference index of Serum or Plasma
33
24
15.69
36.33
6.9
3.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
65
9.13
36.17
1.1
1.5
miu/ml
190.2
292.3
—
5
28
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
53
79
8.24
35.50
10.5
8.9
mg/l
2.0
1.4
4.21
53
74
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
25
11
25.14
34.52
10.6
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
78
182
5.78
33.57
3.3
3.1
e9/l
65.9
73.4
0.87
53
135
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
110
350
4.83
32.60
1.5
1.3
iu/ml
19.3
29.7
0.67
29
121
(3037467) Urinalysis macro (dipstick) panel - Urine
238
1419
15.11
31.27
23.1
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
189
979
4.81
27.64
9.6
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
14
17.99
27.50
1.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
65
153
5.39
27.28
1.6
2.9
g/l
61.2
66.9
4.74
60
145
(3021901) Oxygen saturation in Capillary blood
30
31
10.86
26.41
10.7
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
31
8
43.90
25.55
1.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
159
5.07
25.08
1.2
1.7
—
—
—
0
0
(4035726)
73
207
4.57
24.24
1.9
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
7
46.63
24.20
1.7
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
38
9.17
24.04
6.9
3.8
%
56.5
57.4
0.14
31
38
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
5
60.22
23.57
1.1
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
37
9.08
23.13
6.2
3.1
e9/l
4.0
4.3
0.31
30
37
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
6
50.19
22.86
1.1
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
16
14.24
22.23
2.6
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
14
15.44
22.16
2.6
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
14
15.44
22.16
1.9
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
120
510
3.60
22.04
24.3
4.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
52
124
5.03
21.19
9.9
2.6
e6/l
0.2
0.1
0.44
52
119
(3025941) Bacteria identified in Stool by Culture
50
116
5.14
21.03
1.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
27
33
9.05
20.91
5.1
3.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
30
44
7.61
20.00
13.2
3.6
kpa
5.3
5.0
0.87
30
44
(3027315) Oxygen [Partial pressure] in Blood
30
44
7.61
20.00
13.2
3.6
kpa
8.6
8.7
0.12
30
44
(3012501) Base excess in Blood by calculation
30
44
7.61
20.00
13.2
3.6
mmol/l
2.9
2.3
0.45
20
28
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
13
14.84
19.55
2.7
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
13
14.84
19.55
2.7
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
14
13.78
18.75
1.7
3.6
%
10.8
15.1
—
10
8
(3028626) Oxygen [Partial pressure] in Capillary blood
35
65
6.10
18.66
13.8
3.8
kpa
8.9
8.9
0.02
35
60
(3044889) 12 lead EKG panel
221
1480
5.25
18.62
22.6
3.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
57
162
4.26
18.51
12.3
4.2
mmol/l
1.8
1.7
0.04
46
122
(3003694) ABO and Rh group [Type] in Blood
128
618
3.20
18.27
1.9
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
58
169
4.17
18.20
13.0
4.1
ph
7.4
7.4
0.84
12
17
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
16
12.05
17.29
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
78
288
3.48
17.24
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
171
4.02
17.12
4.0
2.7
ml/min/173m2
37.4
64.0
10.32
37
75
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
231
3.67
17.07
2.9
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
42
7.09
17.02
12.1
3.9
—
—
—
0
0
(3020891) Body temperature
36
75
5.44
16.96
12.3
5.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
64
5.79
16.78
1.5
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
54
159
4.06
16.61
12.3
4.6
mmol/l
1.2
1.2
0.14
54
143
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
21
7
32.55
16.39
1.0
1.0
%
101.0
121.7
—
21
7
(42529406) Shigella sp [Presence] in Stool by Culture
33
66
5.61
16.23
1.5
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
66
5.61
16.23
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
90
375
3.19
16.19
1.8
1.6
pmol/l
506.0
446.1
0.98
81
317
(3019230) Fractional oxyhemoglobin in Venous blood
25
38
7.20
16.07
6.8
6.1
%
63.8
67.6
0.32
25
38
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
32
7.81
15.95
11.3
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
60
5.76
15.77
1.4
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
120
4.35
15.76
2.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
220
1547
4.52
15.43
5.3
3.7
pmol/l
14.0
14.8
5.16
214
1402
(40767503) Oxygen content in Capillary blood by calculation
24
39
6.70
14.48
5.5
2.4
%
16.0
17.7
0.95
16
19
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
19
8
25.55
14.01
1.1
1.1
u/l
9.3
13.8
—
19
8
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
12
12.30
13.64
2.1
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
36
6.60
13.17
8.7
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
138
798
2.63
12.66
5.7
3.6
ng/l
67.1
37.2
1.75
127
549
(3028433) Virus identified in Specimen by Culture
13
12
11.37
12.05
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
5
31.75
11.78
1.5
7.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
64
4.80
11.78
1.3
2.0
g/l
3.3
3.1
0.62
21
53
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
7
24.28
11.72
4.1
2.6
umol/l
24.9
27.3
—
16
7
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
37
6.10
11.68
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
121
3.74
11.67
1.5
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
8
21.25
11.28
6.7
6.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
67
4.58
11.14
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
g/l
3.6
3.8
0.37
21
52
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
g/l
7.9
7.3
0.92
21
56
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
7
22.67
10.81
6.5
6.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
44
5.39
10.73
7.3
6.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
17
8.66
10.72
1.5
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
14
6
24.59
10.36
2.7
6.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
309
2.70
10.32
1.7
1.6
nmol/l
1033.9
1212.0
0.96
61
243
(3022313) Gas panel - Capillary blood
40
132
3.42
10.20
12.9
4.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
5
27.28
9.91
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
102
559
2.39
9.89
12.3
3.6
estimate
0.0
0.0
0.50
51
204
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
58
4.47
9.41
1.4
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
204
2.88
9.38
4.4
3.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
5
25.09
8.99
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
39
5.19
8.99
1.4
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
24
61
4.25
8.83
11.8
4.2
mmol/l
4.0
3.8
1.43
19
55
(3009542) Hematocrit [Volume Fraction] of Blood
240
2008
5.88
8.79
97.4
14.7
%
36.0
40.8
34.65
225
1525
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
53
4.45
8.65
1.4
2.0
g/l
0.1
0.1
0.06
22
53
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
6
20.90
8.55
2.8
6.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
45
4.74
8.53
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
19
7.16
8.52
1.4
9.5
%
9.9
11.8
1.19
13
19
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
115
3.26
8.30
1.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
192
1442
2.43
8.18
4.7
3.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
7
17.90
8.15
1.5
1.1
u/l
12.6
19.6
—
12
7
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
714
2.17
8.14
2.0
1.9
pmol/l
95.9
95.3
0.05
64
370
(3000093) Morphology [Interpretation] in Blood Narrative
15
27
5.85
8.12
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
17
7.36
8.06
1.6
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
48
4.44
7.89
1.4
1.8
g/l
0.0
0.0
0.00
20
48
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
48
4.44
7.89
1.4
1.8
g/l
0.0
0.0
0.00
20
48
(4062490)
15
28
5.64
7.83
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
125
807
2.10
7.60
11.2
3.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
67
3.68
7.03
2.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
43
843
0.41
6.84
3.0
2.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
14
7.40
6.75
2.4
1.4
e9/l
0.1
0.2
—
10
14
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
47
4.05
6.38
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
9
5
18.59
6.31
1.3
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
226
1907
2.93
6.29
8.2
4.3
mu/l
1.9
1.9
0.34
221
1748
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
0
+∞
6.27
1.3
0.0
nmol/l
10.5
—
—
6
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
53
3.80
6.17
1.3
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
16
6.47
6.00
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
94
585
1.97
5.99
10.6
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
71
3.30
5.77
2.8
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
232
2007
3.17
5.73
71.6
12.4
ml/min/173m2
65.6
84.6
17.74
223
1653
(3022217) INR in Platelet poor plasma by Coagulation assay
47
230
2.29
5.58
40.1
18.3
inr
2.0
1.4
—
7
27
(3019150) Specific gravity of Urine by Refractometry
77
457
1.99
5.56
10.2
3.6
kg/l
1.0
1.0
—
5
66
(3016228) CD19 cells/100 cells in Blood
8
5
16.45
5.44
2.4
1.4
%
6.3
7.0
—
8
5
(21494814) CD8 cells/100 lymphocytes in Specimen
8
5
16.45
5.44
2.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
171
2.44
5.44
8.2
3.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
39
4.03
5.34
1.1
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
76
3.08
5.18
3.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
71
3.14
5.12
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
89
2.88
5.01
1.6
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
41
3.83
5.00
1.7
2.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
84
2.91
4.93
6.5
5.9
g/l
0.4
0.3
0.29
16
46
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
29
121
2.58
4.85
12.8
4.8
mmol/l
24.4
25.0
0.53
29
114
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
47
3.57
4.83
1.3
1.8
g/l
0.4
0.9
0.93
11
39
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
5
14.34
4.60
1.7
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
54
3.30
4.58
3.0
3.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
233
0.24
4.33
1.5
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
109
0.00
4.31
0.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
186
2.16
4.09
14.0
3.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
15
6.18
3.85
1.1
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
15
6.18
3.85
1.1
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
236
0.28
3.83
1.4
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
17
5.45
3.54
1.6
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
18
5.14
3.40
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
47
276
1.87
3.38
1.4
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.86
3.37
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
14
5.86
3.37
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
77
525
1.67
3.32
1.5
2.8
ug/l
0.5
0.7
3.55
54
337
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
66
2.69
3.29
1.0
1.5
ug/g
257.1
289.0
—
8
41
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
15
5.47
3.21
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
106
2.29
3.14
2.0
2.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
16
5.13
3.07
1.4
1.7
umol/l
12.1
11.1
—
8
16
(3044242) Glucose [Moles/volume] in Arterial blood
7
12
5.97
3.04
1.1
6.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
17
4.82
2.94
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
30
3.43
2.94
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
31
3.32
2.80
1.5
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
23
4.02
2.80
1.2
1.1
u/ml
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
37
3.06
2.73
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
24
3.85
2.70
1.8
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
212
0.36
2.69
1.1
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
38
2.98
2.61
1.5
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
38
2.98
2.61
1.5
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
15
4.77
2.61
2.7
1.3
u/ml
0.9
0.7
—
7
8
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
15
4.77
2.61
1.7
1.9
g/l
0.9
1.0
—
7
15
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
7
7.26
2.56
1.2
1.0
miu/ml
1609.6
1555.6
—
5
7
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
115
905
1.50
2.55
3.2
4.5
ug/l
1.4
2.0
2.27
97
820
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
21
3.90
2.48
1.1
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
6
12
5.09
2.41
4.7
2.5
min
559.3
517.4
—
6
7
(3035637) Corticotropin [Mass/volume] in Plasma
9
28
3.29
2.33
1.8
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
13
4.70
2.28
1.5
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
13
4.70
2.28
1.5
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
13
4.70
2.28
1.3
4.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
13
4.70
2.28
1.3
4.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
94
723
1.48
2.28
2.9
4.1
%
25.8
21.2
1.62
28
347
(3017732) Neutrophils [#/volume] in Blood
26
144
1.90
2.25
2.8
2.3
e9/l
3.4
4.1
1.04
19
116
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
9
5.64
2.22
1.0
1.3
u/l
287.6
210.8
—
5
9
(4015189)
5
9
5.64
2.22
1.8
3.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.08
2.08
1.4
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
15
4.07
2.05
4.0
2.5
ml
804.2
645.8
—
6
8
(3044927) Protein electrophoresis panel - Urine
7
21
3.40
1.98
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
21
3.40
1.98
2.1
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
236
0.44
1.96
1.3
2.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
16
78
2.12
1.95
1.7
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
33
206
1.69
1.95
2.5
4.7
ug/l
19.7
42.1
0.36
25
164
(3051593) INR in Capillary blood by Coagulation assay
5
11
4.61
1.95
1.2
7.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
12
4.23
1.83
3.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.23
1.83
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
12
4.23
1.83
1.4
6.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
36
2.55
1.76
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
24
2.97
1.73
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.97
1.73
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.97
1.73
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.90
1.72
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
19
3.21
1.67
1.7
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
20
3.05
1.59
2.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
238
2271
2.00
1.56
48.2
13.0
—
—
—
0
0
(3004451) EKG impression Narrative
5
15
3.38
1.53
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
37
2.48
1.49
4.4
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
28
2.54
1.46
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
67
1.99
1.41
4.2
2.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
29
2.45
1.40
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
41
2.24
1.38
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
41
0.00
1.32
0.0
1.0
—
—
—
0
0
(3013512) EKG study
75
606
1.34
1.28
7.3
3.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
25
2.43
1.25
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
25
2.43
1.25
2.5
1.7
ug/l
11.3
18.7
—
6
25
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
63
1.95
1.25
1.4
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
21
2.41
1.09
1.2
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
123
0.48
1.08
1.2
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
10
52
1.96
1.07
1.1
2.1
u/l
1.4
3915.9
—
5
17
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
49
1.87
0.99
2.2
2.2
e6/l
1217.2
2370.3
—
9
40
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
49
1.87
0.99
2.2
2.0
e6/l
6.4
10.1
—
9
39
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
141
1.53
0.98
1.2
1.3
—
35.8
—
0
8
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.3
—
61.7
—
0
8
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
3.2
—
0
13
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
31
0.00
0.97
0.0
1.1
—
0.6
—
0
11
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
31
0.00
0.97
0.0
1.2
—
8.5
—
0
18
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
36
272
1.38
0.94
2.0
2.6
ug/g
198.7
108.5
0.73
31
222
(3022145) Colonoscopy Study observation
33
247
1.39
0.91
1.6
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
29
2.09
0.90
2.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
88
1.63
0.86
4.1
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
31
1.96
0.85
1.3
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
156
1.45
0.82
2.3
2.5
—
19.7
—
0
8
(3019225) pH of Specimen
27
200
1.39
0.80
19.2
4.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.1
—
10.0
—
0
14
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
493
1.26
0.77
1.4
1.3
u/ml
0.4
1.3
1.43
17
135
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
58
1.57
0.70
1.7
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
41
1.73
0.70
2.3
2.3
—
—
—
0
0
(1002224) Polysomnography panel
7
119
0.58
0.69
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
27
1.87
0.69
1.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
398
1.25
0.68
1.5
1.6
—
—
—
0
0
(4024509)
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
54
1.50
0.58
1.1
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
36
1.68
0.57
1.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
45
1.57
0.49
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
92
0.64
0.43
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
70
1.45
0.42
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
33
1.53
0.41
2.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
33
1.53
0.41
2.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
526.9
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
242.0
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
36.2
—
0
9
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
17
0.00
0.41
0.0
1.2
—
13872.2
—
0
12
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
18
0.00
0.40
0.0
1.3
—
59.3
—
0
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
15.2
—
1325.8
—
0
19
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(4034850)
9
70
1.30
0.37
15.1
12.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
81
1.37
0.37
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
82
1.36
0.34
1.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
87
0.68
0.33
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
83
1.34
0.32
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
83
1.34
0.32
1.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
55
1.28
0.30
4.6
3.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
62
1.30
0.28
1.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
132
1.23
0.26
4.4
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
74
0.67
0.26
1.0
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
245
1.16
0.26
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
77
1.18
0.24
1.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
103
0.77
0.21
1.4
1.9
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
11
0.00
0.21
0.0
2.4
—
5.7
—
0
11
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
9.5
—
0
12
(4211845)
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.1
—
7.8
—
0
12
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
10.8
—
0.6
—
0
14
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
348
1.11
0.19
1.3
1.3
u/ml
24.7
9.3
0.38
16
145
(36660697) Celiac disease serology panel - Serum
21
186
1.14
0.17
1.3
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
63
1.11
0.17
1.4
1.5
mu/l
290.3
355.4
—
7
58
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
225
0.88
0.17
1.1
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
264
0.90
0.15
17.3
7.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
105
1.15
0.11
8.0
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
44
1.14
0.10
3.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
81
0.86
0.07
1.4
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
112
0.98
0.00
1.2
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
48.3
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.8
—
154.3
—
0
6
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
17.3
—
0
7
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
49
1.02
0.00
1.6
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
1.6
—
0
7
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.3
—
0
5
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
21.8
—
0
5
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.7
—
7.6
—
0
9
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
89.1
—
0
7
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Z21_LUNG_TRANSPLANT_STATUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_LUNG_TRANSPLANT_STATUS | 6.846 [4.54, 10.33] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.826 |
During the follow-up period (1.1.1998 — 31.12.2019), 72 out of 230 females with Z21_LUNG_TRANSPLANT_STATUS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_LUNG_TRANSPLANT_STATUS | 5.555 [3.49, 8.85] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 314 males with Z21_LUNG_TRANSPLANT_STATUS died.
Mortality risk
Mortality risk for people of age
years, who have Z21_LUNG_TRANSPLANT_STATUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.828% | 1.106% |
| 5 | 4.172% | 6.44% |
| 10 | 11.641% | 15.219% |
| 15 | 20.622% | 26.458% |
| 20 | 34.009% | 41.682% |
Relationships between endpoints
↥Index endpoint: Z21_LUNG_TRANSPLANT_STATUS – Lung transplant status
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data